The proprietary Subcuject device platform:
Low cost, reliable and versatile
The Subcuject WBI consists of only few parts and very few moving parts. This, combined with the inexpensive nature of the osmotic actuator results in low manufacturing price – comparable to the manufacturing price of an autoinjector as well as a robust and reliable principle.
Patients, therapies, drug substances and dose sizes are not equal across a product portfolio. This requires device customization. Our modular design enables straight forward configuration of the optimal combination of modules – across the product portfolio.
The Subcuject WBI Platform does not require electronics. Instead, it has the flexibility to accommodate electronics as an add-on e.g. for connectivity or data collection.